High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer.
Momoe ItsumiMasaki ShiotaYohei SekinoMiho UshijimaEiji KashiwagiArio TakeuchiJunichi InokuchiShunichi KajiokaTakeshi UchiumiMasatoshi EtoPublished in: The Prostate (2020)
Taken together, this study identifies 5-HT5A receptor as a promising therapeutic target for prostate cancer via its interaction with AR signaling.